From April 23, 2023 to June 30, 2023, the company has repurchased 1,165,700 shares, representing 0.27% for CNY 25 million. With this, the company has completed the repurchase of 1,165,700 shares, representing 0.27% for CNY 25 million under the buyback announced on April 25, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.35 CNY | -18.75% | -.--% | -45.40% |
Jun. 06 | Hainan Poly Pharm's Unit Gets Nod to Market Raw Drug Ingredient Gadoterate Gluconamide | MT |
May. 14 | China Grants Registration Approval for Antibacterial Drug | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.40% | 764M | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.87% | 248B | |
-1.64% | 219B | |
+11.11% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- 300630 Stock
- News Hainan Poly Pharm. Co., Ltd
- Tranche Update on Hainan Poly Pharm. Co., Ltd's Equity Buyback Plan announced on April 25, 2023.